The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

Journal of Clinical Investigation

Volumn 102, Issue 9, 1998, Pages 1662-1673

  Kleeff, Jörg ^a   Ishiwata, Toshiyuki ^a   Kumbasar, Asli ^a,b   Friess, Helmut ^c   Büchler, Markus W ^c   Lander, Arthur D ^a   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cancer; Glypican 1; Growth factors; Heparin binding; Pancreas

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLYPICAN; GROWTH FACTOR; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PROTEOHEPARAN SULFATE; RNA;

ADULT; AGED; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOGENESIS; PANCREAS CANCER; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032213027     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4105     Document Type: Article

References (66)

1. LeBaron, R.G., A. Höök, J.D. Esko, S. Gay, and M. Höök. 1989. Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion. J. Biol. Chem. 264:7950-7956.
2. Stanley, M.J., B.F. Liebersbach, W. Liu, D.J. Anhalt, and R.D. Sanderson. 1995. Heparan sulfate mediated cell aggregation syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B-lymphoid cells. J. Biol. Chem. 10:5077-5083.
3. David, G. 1993. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1023-1030.
4. Rapraeger, A.C., S. Guimond, A. Krufka, and B.B. Olwin. 1994. Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol. 245:219-240.
5. Bernfield, M., R. Kokenyesi, M. Kato, M.T. Hinkes, J. Spring, R.L. Gallo, and E.J. Lose. 1992. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Ann. Rev. Cell biol. 8:365-393.
6. David, G., V. Lorie, B. Decock, P. Marynen, J.-J. Cassiman, and H. Van den Berghe. 1990. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J. Cell Biol. 111:3165-3176.
7. Stipp, C.S., E.D. Litwack, and A.D. Lander. 1994. Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J. Cell Biol. 124:149-160.
8. Filmus, J., J.G. Church, and R.N. Buick. 1988. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol. Cell. Biol. 8:4243-4249.
9. Watanabe, K., H. Yamada, and Y. Yamaguchi. 1995. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J. Cell Biol. 130:1207-1218.
10. Saunders, S., S. Paine-Saunders, and A.D. Lander. 1997. Expression of the cell surface glypican-5 is developmentally regulated in kidney, limb, and brain. Dev. Biol. 190:78-93.
11. Ivins, J.K., E.D. Litwack, A. Kumbasar, C.S. Stipp, and A.D. Lander. 1997. Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Dev. Biol. 184:320-332.
12. Litwack, E.D., J.K. Ivins, A. Kumbasar, S. Paine-Saunders, C.S. Stipp, and A.D. Lander. 1998. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dynamics. 211:72-87.
13. Asundi, V.K., B.F. Keister, R.C. Stahl, and D.J. Carey. 1997. Developmental and cell-type-specific expression of cell surface heparan sulfate proteoglycans in the rat heart. Exp. Cell Res. 230:145-153.
14. Carey, D.J., and D.M. Evans. 1989. Membrane anchoring of heparan sulfate proteoglycans by phosphatidylinositol and kinetics of synthesis of peripheral and detergent-solubilized proteoglycans in Schwann cells. J. Cell Biol. 108:1891-1897.
15. Rapraeger, A.C., M. Jalkanen, E. Endo, J. Koda, and M. Bernfield. 1995. The cell surface proteoglycan from mouse mammary epithelial cells bears chondroitin sulfate and heparan sulfate glycosaminoglycans. J. Biol. Chem. 260: 11046-11052.
16. Yayon, A., M. Klagsbrun, J.D. Esko, P. Leder, and D.M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 64:841-848.
17. Bonneh-Barkey, D., M. Shlissel, B. Berman, E. Shaoul, A. Admont, I. Vlodavsky, D.J. Carey, V.K. Asundi, R. Reich-Slotky, and D. Ron. 1997. Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J. Biol. Chem. 272:12415-12421.
18. Fukuda, K., Y. Inui, S. Kawata, S. Higashiyama, Y. Matsuda, Y. Maeda, T. Igura, S. Yoshida, N. Tanaguchi, and Y. Matsuzawa. 1995. Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats. Arterioscler. Thromb. Vasc. Biol. 15:1680-1687.
19. Sakata, H., S.J. Stahl, W.G. Taylor, J.M. Rosenberg, K. Sakaguchi, P.T. Wingfield, and J.S. Rubin. 1997. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J. Biol. Chem. 272:9457-9463.
20. Itoh, K., and S.Y. Sokol. 1994. Heparan sulfate proteoglycans are required for mesoderm formation in Xenopus embryos. Development. 120:2703-2711.
21. Reichsman, F., L. Smith, and S. Cumberledge. 1996. Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J. Cell Biol. 135:819-827.
22. Warshaw, A.L., and C. Fernandez-del Castillo. 1992. Pancreatic carcinoma. N. Engl. J. Med. 326:455-465.
23. Korc, M. 1996. Growth factors in pancreatic cancer. In Advances in Pancreatic Disease. C.G. Dervenis, editor. Georg Thieme Verlag Stuttgart, New York. 34-41.
24. Yamanaka, Y., H. Friess, M. Büchler, H.G. Beger, E. Uchida, M. Onda, M.S. Kobrin, and M. Korc. 1993. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res. 53:5289-5296.
25. Ebert, M., M. Yokoyama, M.S. Kobrin, H. Friess, M.E. Lopez, M.W. Büchler, G.R. Johnson, and M. Korc. 1994. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res. 54:3959-3962.
26. Kobrin, M.S., H. Funatomi, H. Friess, M.W. Büchler, P. Stathis, and M. Korc. 1994. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 202:1705-1709.
27. Kornmann, M., T. Ishiwata, H.G. Beger, and M. Korc. 1997. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene. 15: 1417-1424.
28. Litwack, E.D., C.S. Stipp, A. Kumbasar, and A.D. Lander. 1994. Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. J. Neuroscience. 14:3713-3724.
29. Arreaza, G., and D.A. Brown. 1995. Sorting and intracellular trafficking of a glycosylphosphatidylinositol-anchored protein and two hybrid transmembrane proteins with the same ectodomain in Madin-Darby canine kidney epithelial cells. J. Biol. Chem. 270:23641-23647.
30. Korc, M., B. Chandrasekar, Y. Yamanaka, H. Friess, M.W. Büchler, and H.G. Beger. 1992. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha. J. Clin. Invest. 90:1352-1360.
31. Raitano, A.B., and M. Korc. 1990. Tumor necrosis factor up-regulates γ-interferon binding in a human carcinoma cell line. J. Biol. Chem. 265:10466-10472.
32. Baldwin, R.L., and M. Korc. 1993. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors. 8: 23-34.
33. Rapraeger, A.C., A. Krufka, and B.B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 252:1705-1708.
34. Lander, A.D., C.S. Stipp, and J.K. Ivins. 1995. The glypican family of heparan sulfate proteoglycans: major cell-surface proteoglycans of the developing nervous system. Perspect. Dev. Neurobiol. 1:1-7.
35. Herndon, M.E., and A.D. Lander. 1990. A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system. Neuron. 4:949-961.
36. Ornitz, D.M., A. Yayon, J.G. Flanagan, C.M. Svahn, E. Levi, and P. Leder. 1992. Heparin is required for cell-free binding of basic fibrobiast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12:240-247.
37. Olwin, B.B., and A. Rapraeger. 1992. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118:631-639.
38. Chintala, S.K., R.R. Miller, and C.A. McDevitt. 1995. Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes. Arch. Biochem. Biophys. 316:227-234.
39. Delhedde, M., E. Deudon, B. Boilly, and H. Hondermarck. 1996. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. Exp. Cell Res. 229:398-406.
40. Roghani, M., A. Mansukhani, P. Dell'Era, P. Bellosta, C. Basilico, and D. Moscatelli. 1994. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269:3976-3984.
41. Spivak-Kroizman, T., M.A. Lemmon, I. Dikic, J.E. Landbury, D. Pinchasi, J. Huang, M. Jaye, C. Crumley, J. Schlessinger, and I. Lax. 1994. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell. 79:1015-1024.
42. Pantoliano, M.W., R.A. Horlick, B.A. Springer, D.E. Van Dick, T. Tobery, D.R. Wetmore, J.D. Lear, A.T. Nahapetian, J.D. Bradley, and W.O. Sisk. 1994. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry. 33:10229-10248.
43. Schlessinger, J., I. Lax, and M. Lemmon. 1995. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell. 83:357-360.
44. Saksela, O., and D.B. Rifkin. 1990. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110:767-775.
45. Vlodavsky, I., H.-Q. Miao, B. Medalion, P. Danagher, and D. Ron. 1996. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 15:177-186.
46. Miyaza, Y., Y. Shinomura, S. Higashiyma, S. Kanayama, Y. Higashimoto, S. Tsutsui, S. Zushi, N. Taniguchi, and Y. Matsuzawa. 1996. Heparin-binding EGF-like growth factor is an autocrine growth factor for rat gastric epithelial cells. Biochem. Biophys. Res. Commun. 223:36-41.
47. Chiang, M.K., and J.G. Flanagan. 1995. Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors. 12:1-10.
48. Nakato, H., T.A. Futch, and S.B. Selleck. 1995. The division abnormally delayed (dally) gene: a putative integral membrane proteoglycan required for cell division patterning during postembryonic development of the nervous system in Drosophila. Development. 121:3687-3702.
49. Pilia, G., R.M. Hughes-Benzie, A. MacKenzie, P. Baybayan, E.Y. Chen, R. Huber, G. Neri, A. Cao, A. Forabosco, and D. Schlessinger. 1996. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12:241-247.
50. Lindsay, S., M. Ireland, O. O'Brien, J. Clayton-Smith, J.A. Hurst, J. Mann, T. Cole, J. Sampson, S. Slaney, D. Schlesinger, J. Burn, and G. Pilia. 1997. Large scale deletions of the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J. Med. Genet. 34:480-483.
51. Carey, D.J., K. Conner, V.K. Asundi, D.J. Omahony, R.C. Stahl, L. Showalter, G. Smith, J. Hartman, and L.I. Rothblum. 1997. cDNA cloning, genomic organization, and in vivo expression of rat N-syndecan. J. Biol. Chem. 272:2873-2879.
52. Schwarz, L.C., T. Inoue, T. Irimura, J.E. Damen, A.H. Greenberg, and J.A. Wright. 1990. Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes. Cancer Lett. 51:187-192.
53. Laskov, R., R.I. Michaeli, H. Sharir, E. Yefenof, and I. Vlodavsky. 1991. Production of heparanase by normal and neoplastic murine B-lymphocytes. Int. J. Cancer. 47:92-98.
54. Freeman, C., and C.R. Parish. 1997. A rapid quantitative assay for the detection of mammalian heparanase activity. Biochem. J. 325:229-237.
55. Kosir, M.A., C.C. Quinn, K.L. Zukowski, D.J. Grignon, and S. Ledbetter. 1997. Human prostate carcinoma cells produce extracellular heparanase. J. Surg. Res. 67:98-105.
56. Prigent, S.A., and N.R. Lemoine. 1992. The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res. 4:1-24.
57. Raab, G., and M. Klagsbrun. 1997. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta. 1333:F179-F199.
58. Filla, M.S., P. Dam, and A.C. Rapraeger. 1998. The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J. Cell. Physiol. 174:310-321.
59. De Klerk, D.P. 1984. Glycosaminoglycans of human prostatic cancer. J. Urol. 131:1008-1012.
60. De Klerk, D.P. 1985. The glycosaminoglycans of human bladder cancers of varying grade and stage. J. Urol. 134:978-981.
61. Kovalszky, I., Z. Scharff, and A. Jeney. 1993. Potential markers (enzymes, proteoglycans) for human liver tumors. Acta Biomed. Ateneo Parmense. 64:157-163.
62. Nackaerts, K., E. Verbeken, G. Deneffe, B. Vandershueren, M. Demedts, and G. David. 1997. Heparan sulfate proteoglycan expression in human lung-cancer cells. Int. J. Cancer. 74:335-345.
63. Levy, P., A. Munier, S. Baron-Delage, Y. DiGioia, C. Gespach, J. Capeau, and G. Cherqui. 1996. Syndecan-1 alterations during the tumorigenic progress of human colonie Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. Br. J. Cancer. 74:421-423.
64. Inki, P., H. Joensuu, R. Gronman, P. Klemi, and M. Jalkanen. 1994. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br. J. Cancer. 70:319-323.
65. Kloppel, G., and B. Maillet. 1991. Chronic pancreatitis: evolution of the disease. Hepatogastroenterology. 38:408-412.
66. Friess, H., J. Kleeff, and M.W. Büchler. 1997. Growth factors and growth factor receptors in chronic pancreatitis. In Advances in Pancreatic Disease. G.G. Dervenis, editor. Georg Thieme Verlag Stuttgart, New York. 26-32.